weight-loss and diet control industry
Page 7 of 10
HealthWeight-loss drugs like Ozempic and Wegovy come with potentially serious side effects, study finds
By Madison Muller and BloombergOctober 5, 2023
LifestyleWeight-loss-aiding drugs Ozempic and Wegovy are dampening food sales, top Walmart exec says
By Chloe TaylorOctober 5, 2023
HealthWeight-loss drugs like Ozempic and Wegovy may be risky for older people because they melt away all-important muscles, experts say
By Madison Muller and BloombergSeptember 27, 2023
HealthWeight-loss drugs like Ozempic are in such huge demand that spending on them will hit $100 billion by 2035, analyst says
By Angel Adegbesan and BloombergSeptember 22, 2023
TechTikTok’s hidden ‘Ozempic economy,’ where weight-loss influencers trade referrals for drug discounts and cash
By Alexandra SternlichtSeptember 19, 2023
HealthSome weight loss pills used as alternatives to Ozempic and Wegovy contain toxic ingredients that are ‘potentially life-threatening’
By Madison Muller and BloombergSeptember 14, 2023
RetailWegovy maker Novo Nordisk leapfrogs LVMH to become Europe’s most valuable company after it takes its ‘miracle’ weight loss drug to the U.K.
By Prarthana PrakashSeptember 5, 2023
HealthWeight loss drugs are such big sellers now that Ozempic’s maker has overtaken LVMH as Europe’s most valuable company
By Jonas Ekblom, Marthe Fourcade and BloombergSeptember 1, 2023
HealthBlockbuster weight loss drugs Ozempic and Wegovy cost Americans up to 10 times more than what other countries pay, research shows
By Christiaan HetznerAugust 18, 2023
HealthA pharma company helping Elon Musk shed weight is now worth more than the entire economy of Denmark
By Prarthana PrakashAugust 11, 2023
HealthWeight-loss stocks soar up to 15% after obesity-drug study shows an added benefit that may be a ‘huge win’ for future sales
By Angel Adegbesan, Jameelah Robinson and BloombergAugust 8, 2023
HealthPopular weight-loss injectable Wegovy cuts risk of heart attack and stroke by 20%, company says
By Erin PraterAugust 8, 2023
NewslettersWeightWatchers CEO says the Ozempic era signals ‘the end of diet culture.’ Could we be so lucky?
By Maria Aspan and Joey AbramsJuly 24, 2023
Most Popular
